7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Cullin RING E3 ubiquitin ligases (CRLs) function in the ubiquitin proteasome system to catalyze the transfer of ubiquitin from E2 conjugating enzymes to specific substrate proteins. CRLs are large dynamic complexes and attractive drug targets for the development of small-molecule inhibitors and chemical inducers of protein degradation. The atomic details of whole CRL assembly and interactions that dictate subunit specificity remain elusive. Here we present the crystal structure of a pentameric CRL2 VHL complex, composed of Cul2, Rbx1, Elongin B, Elongin C, and pVHL. The structure traps a closed state of full-length Cul2 and a new pose of Rbx1 in a trajectory from closed to open conformation. We characterize hotspots and binding thermodynamics at the interface between Cul2 and pVHL-EloBC and identify mutations that contribute toward a selectivity switch for Cul2 versus Cul5 recognition. Our findings provide structural and biophysical insights into the whole Cul2 complex that could aid future drug targeting.

          Graphical Abstract

          Highlights

          • First crystal structure of the CRL2 VHL complex

          • Full-length structure of Cullin-2 interacting with Rbx1

          • Suggested trajectory of the Rbx1 RING domain en route to the fully active E3 ligase

          • Biophysical data reveal basis for Cul2 versus Cul5 recognition

          Abstract

          Cardote et al. describe a crystal structure of a pentameric CRL2 VHL complex consisting of Cul2, Rbx1, Elongin B, Elongin C, and pVHL. The structure traps a closed state of full-length Cul2, and additional biophysical characterization of the binding properties identifies features that contribute to Cul2 versus Cul5 recognition.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          Solvent content of protein crystals.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use.

            One of the most important aspects of macromolecular structure refinement is the use of prior chemical knowledge. Bond lengths, bond angles and other chemical properties are used in restrained refinement as subsidiary conditions. This contribution describes the organization and some aspects of the use of the flexible and human/machine-readable dictionary of prior chemical knowledge used by the maximum-likelihood macromolecular-refinement program REFMAC5. The dictionary stores information about monomers which represent the constitutive building blocks of biological macromolecules (amino acids, nucleic acids and saccharides) and about numerous organic/inorganic compounds commonly found in macromolecular crystallography. It also describes the modifications the building blocks undergo as a result of chemical reactions and the links required for polymer formation. More than 2000 monomer entries, 100 modification entries and 200 link entries are currently available. Algorithms and tools for updating and adding new entries to the dictionary have also been developed and are presented here. In many cases, the REFMAC5 dictionary allows entirely automatic generation of restraints within REFMAC5 refinement runs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Induced protein degradation: an emerging drug discovery paradigm

              Small-molecule drug discovery has traditionally focused on occupancy of a binding site that directly affects protein function. This article discusses emerging technologies, such as proteolysis-targeting chimaeras (PROTACs), that exploit cellular quality control machinery to selectively degrade target proteins, which could have advantages over traditional approaches, including the potential to target proteins that are not currently therapeutically tractable.
                Bookmark

                Author and article information

                Contributors
                Journal
                Structure
                Structure
                Structure(London, England:1993)
                Cell Press
                0969-2126
                1878-4186
                06 June 2017
                06 June 2017
                : 25
                : 6
                : 901-911.e3
                Affiliations
                [1 ]Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK
                Author notes
                []Corresponding author a.ciulli@ 123456dundee.ac.uk
                [2]

                Lead Contact

                Article
                S0969-2126(17)30127-2
                10.1016/j.str.2017.04.009
                5462531
                28591624
                89f0fcc6-2599-4851-ac07-97fe84fe4211
                © 2017 The Author(s)

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 28 February 2017
                : 7 April 2017
                : 28 April 2017
                Categories
                Article

                Molecular biology
                cullin-ring e3 ubiquitin ligases,protein-protein interactions,vhl,cullin-2,ring domain proteins

                Comments

                Comment on this article